Rockefeller Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,106
| Closed | -$3.48M | – | 1832 |
|
|
2023
Q2 | $3.48M | Buy |
9,106
+5,935
| +187% | +$2.27M | 0.01% | 683 |
|
|
2023
Q1 | $1.1M | Sell |
3,171
-255
| -7% | -$88.3K | ﹤0.01% | 1032 |
|
|
2022
Q4 | $804K | Sell |
3,426
-826
| -19% | -$194K | ﹤0.01% | 1090 |
|
|
2022
Q3 | $1.05M | Sell |
4,252
-162
| -4% | -$39.8K | 0.01% | 995 |
|
|
2022
Q2 | $1.33M | Sell |
4,414
-999
| -18% | -$302K | 0.01% | 903 |
|
|
2022
Q1 | $2.22M | Sell |
5,413
-4,003
| -43% | -$1.64M | 0.01% | 768 |
|
|
2021
Q4 | $4.42M | Sell |
9,416
-246
| -3% | -$115K | 0.02% | 578 |
|
|
2021
Q3 | $4.1M | Buy |
9,662
+2,674
| +38% | +$1.13M | 0.02% | 534 |
|
|
2021
Q2 | $2.51M | Buy |
6,988
+3,093
| +79% | +$1.11M | 0.01% | 653 |
|
|
2021
Q1 | $1.1M | Buy |
3,895
+175
| +5% | +$49.3K | 0.01% | 753 |
|
|
2020
Q4 | $1.05M | Buy |
3,720
+2
| +0.1% | +$566 | 0.01% | 681 |
|
|
2020
Q3 | $1.02M | Buy |
3,718
+182
| +5% | +$50K | 0.01% | 592 |
|
|
2020
Q2 | $803K | Buy |
3,536
+1,889
| +115% | +$429K | 0.01% | 588 |
|
|
2020
Q1 | $251K | Buy |
1,647
+1,599
| +3,331% | +$244K | ﹤0.01% | 767 |
|
|
2019
Q4 | $7K | Buy |
+48
| New | +$7K | ﹤0.01% | 1719 |
|
|
2019
Q2 | – | Sell |
-326
| Closed | -$36K | – | 2017 |
|
|
2019
Q1 | $36K | Buy |
+326
| New | +$36K | ﹤0.01% | 1019 |
|